MARSEILLE, France, Dec. 21 Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium ...
-- Phase III trials of OGX-011 in first- and second-line advanced prostate cancer and non-small cell lung cancer, expected to begin in 2010 and early 2011 -- -- Significantly strengthens Teva's oncology offerings with novel therapeutic ...
SEATTLE, Dec. 18 Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no ...
QUEBEC CITY , Dec. 18 /PRNewswire-FirstCall/ - Æterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with ...
Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)-652-2626 Intl: +1 805-652-2626 ...
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group Dodi Handy, President and CEO ( Twitter: @dodihandy ) For Media Inquiries: Kathy Addison, Director, Elite Media Group ...
FLUSHING, N.Y. , Dec. 17 /PRNewswire-USNewswire/ -- A 58-year-old man who lives in Corona , Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not ...
JACKSON, N.J. , Dec. 17 -- The Center for Modeling Optimal Outcomes, LLC, a New Jersey based think tank focused on the application of neuroscience in business, inadvertently discovered a scientifically verifiable model for assessing ...
SEATTLE, Dec. 17 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review the New Drug Application (NDA) for ...
WASHINGTON, Dec. 16 As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill. This new cancer ...
Researchers have unveiled a personalized blood test to monitor brain cancer progression more effectively.
Many Chinese cancer patients use Traditional Chinese Medicine alongside treatment, driven by cultural beliefs and health goals, often discussed with oncologists.
A new drug combination shows promise for colon cancer patients whose disease no longer responds to standard chemotherapy treatments, offering new hope.
Genetic analysis reveals how chimeric RNA in prostate cancer varies across populations, offering new paths for precision treatment.
K-TRACK™ ctDNA test from Gene Solutions predicts cancer relapse up to 19.5 months early with up to 96.3% accuracy, bringing affordable precision oncology to Asia.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers